Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Receivables (2016 - 2025)

Historic Receivables for CV Sciences (CVSI) over the last 13 years, with Q3 2025 value amounting to $405000.0.

  • CV Sciences' Receivables fell 402.84% to $405000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $405000.0, marking a year-over-year decrease of 402.84%. This contributed to the annual value of $522000.0 for FY2024, which is 2111.37% up from last year.
  • According to the latest figures from Q3 2025, CV Sciences' Receivables is $405000.0, which was down 402.84% from $545000.0 recorded in Q2 2025.
  • In the past 5 years, CV Sciences' Receivables ranged from a high of $8.2 million in Q3 2021 and a low of $405000.0 during Q3 2025
  • Over the past 5 years, CV Sciences' median Receivables value was $666000.0 (recorded in 2023), while the average stood at $3.5 million.
  • Per our database at Business Quant, CV Sciences' Receivables surged by 20610.85% in 2022 and then crashed by 9398.55% in 2023.
  • Over the past 5 years, CV Sciences' Receivables (Quarter) stood at $2.3 million in 2021, then surged by 206.11% to $7.2 million in 2022, then tumbled by 93.99% to $431000.0 in 2023, then grew by 21.11% to $522000.0 in 2024, then decreased by 22.41% to $405000.0 in 2025.
  • Its Receivables was $405000.0 in Q3 2025, compared to $545000.0 in Q2 2025 and $430000.0 in Q1 2025.